Capricor Therapeutics to Present at Upcoming Oppenheimer and Needham Healthcare Conferences
Mar 21, 2018 11:00 am UTC| Business
LOS ANGELES, March 21, 2018 -- Capricor Therapeutics (NASDAQ:CAPR) today announced that it will participate in two upcoming investment banking conferences, Oppenheimer’s 28th Annual Healthcare Conference and the Needham...
Recro Pharma to Present at the 17th Annual Needham Healthcare Conference
Mar 21, 2018 11:00 am UTC| Business
MALVERN, Pa., March 21, 2018 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced that Gerri...
Nabriva Therapeutics Appoints Jennifer Schranz, M.D., as Chief Medical Officer
Mar 21, 2018 11:00 am UTC| Business
DUBLIN, Ireland and KING OF PRUSSIA, Pa., March 21, 2018 -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to...
gr8 People Names Rachael McCarthy CFO to Take Company through Next Phase of Growth
Mar 21, 2018 11:00 am UTC| Business
PHILADELPHIA, March 21, 2018 -- gr8 People Inc., a leader in enterprise recruiting software for Corporate and Recruiting Process Outsourcing (RPO) Enterprises, announced today the appointment of Rachael McCarthy as...
Mar 21, 2018 11:00 am UTC| Business
SEATTLE and PHILADELPHIA, March 21, 2018 -- Nohla Therapeutics, a leading developer of universal donor cell therapies for patients with hematologic malignances and other critical diseases, and WuXi AppTec Advanced...
Bringing Generations Together Through Music
Mar 21, 2018 11:00 am UTC| Business
DALLAS, March 21, 2018 -- According to research, music and intergenerational interaction1 can enhance cognitive abilities and quality of life in children2, parents, and seniors3. As part of its commitment to creating an...
Leap Therapeutics to Present at the 2018 Needham & Company 17th Annual Healthcare Conference
Mar 21, 2018 11:00 am UTC| Business
CAMBRIDGE, Mass., March 21, 2018 -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D, Chairman,...